These findings were consistent with those reported by others8,17 and demonstrated that the MIR142 mutations identified in leukemia patients result in loss of function, providing a strong rationale for using Mir142 knockout (KO) mice to investigate the role of MIR142 mutations in AML etiology. This evidence concerns the gene MIR142 and leukemia.